7-140778061-T-G
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001374258.1(BRAF):c.1567A>C(p.Lys523Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K523E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001374258.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BRAF | NM_001374258.1 | c.1567A>C | p.Lys523Gln | missense_variant | 13/20 | ENST00000644969.2 | |
BRAF | NM_004333.6 | c.1447A>C | p.Lys483Gln | missense_variant | 12/18 | ENST00000646891.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BRAF | ENST00000644969.2 | c.1567A>C | p.Lys523Gln | missense_variant | 13/20 | NM_001374258.1 | |||
BRAF | ENST00000646891.2 | c.1447A>C | p.Lys483Gln | missense_variant | 12/18 | NM_004333.6 | P4 | ||
ENST00000700122.1 | n.502+3193T>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Cardio-facio-cutaneous syndrome Pathogenic:1Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 02, 2014 | The Lys483Gln variant in BRAF has been identified in one proband with clinical f eatures of Cardio-facio-cutaneous syndrome, and was not identified in either of this individual's parents (LMM unpublished data). This variant has not been iden tified in large population studies. In addition, another variant at the same res idue (Lys483Asn) was identified as a de novo variant in an individual with featu res of a Noonan spectrum disorder (LMM unpublished data). Computational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIF T) suggest that the Lys483Gln variant may impact the normal function of the prot ein. In summary, this variant is likely pathogenic, though additional studies ar e required to fully establish its clinical significance. - |
not provided, no classification provided | phenotyping only | GenomeConnect - CFC International | - | Variant interpreted as Likely pathogenic and reported on 04-02-2014 by lab or GTR ID 21766. GenomeConnect - CFC International assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); The majority of missense variants in this gene are considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Located within protein kinase domain;ATP binding site (PMID: 19624854); This variant is associated with the following publications: (PMID: 26918529, 19624854, 33839364, 34625582, 29696744) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at